Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.

Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Exenatide 2 MG;   Drug: Dapagliflozin 10 MG Sponsor:   Consano Clinical Research, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials